Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in acute myocardial infarction study trial

American Heart Journal

Volumn 163, Issue 1, 2012, Pages 104-111

  Ferrante, Giuseppe ^a   Presbitero, Patrizia ^a   Corrada, Elena ^a   Campo, Gianluca ^b   Bolognese, Leonardo ^c   Vassanelli, Corrado ^d   Colangelo, Salvatore ^e   De Cesare, Nicoletta ^f   E Rodriguez, Alfredo ^g   Bramucci, Ezio ^h   Moreno, Raul ⁱ   Piva, Tommaso ^j   Sheiban, Imad ^k   Pasquetto, Giampaolo ^l   Prati, Francesco ^e   Nazzaro, Marco S ^m   Ferrari, Roberto ^b   Valgimigli, Marco ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e MOLINETTE HOSPITAL   (Italy)

^f Policlinico S Marco   (Italy)

^g Sanatorio Otamendi y Miroli   (Argentina)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j Azienda Ospedaliera Umberto I   (Italy)

^k UNIVERSITY OF TURIN   (Italy)

^l Civic Hospital   (Italy)

^m SAN CAMILLO FORLANINI HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; RAPAMYCIN; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ARRHYTHMIAS, CARDIAC; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOSUPPRESSIVE AGENTS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SEX FACTORS; SIROLIMUS; TYROSINE;

EID: 83455164857     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.09.026     Document Type: Article

References (25)

1. R. Virmani, F.D. Kolodgie, and A.P. Burke Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275 (Pubitemid 30262927)
2. B.A. Vakili, R.C. Kaplan, and D.L. Brown Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction Circulation 104 2001 3034 3038 (Pubitemid 34014053)
3. D. Antoniucci, R. Valenti, and G. Moschi Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction Am J Cardiol 87 2001 289 293 (Pubitemid 32144868)
4. C.T. Watanabe, C. Maynard, and J.L. Ritchie Comparison of short-term outcomes following coronary artery stenting in men versus women Am J Cardiol 88 2001 848 852 (Pubitemid 32995916)
5. C.I. Cheng, K.H. Yeh, and H.W. Chang Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention Chest 126 2004 47 53
6. G. De Luca, H. Suryapranata, and J.H. Dambrink Sex-related differences in outcome after ST segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study Am Heart J 148 2004 852 856
7. A.J. Lansky, C. Pietras, and R.A. Costa Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial Circulation 111 2005 1611 1618 (Pubitemid 40525160)
8. Z. Motovska, P. Widimsky, M. Aschermann, and PRAGUE Study Group Investigators The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies Heart 94 2008 e5
9. Y. Liu, L.F. Wang, and X.F. Yang Gender differences in efficacy of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction Chin Med J 121 2008 2374 2378
10. G. De Luca, C.M. Gibson, and M. Gyöngyösi Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation J Thromb Thrombolysis 30 2010 342 346
11. K.D. Sjauw, N.K. Stegenga, and A.E. Engström The influence of gender on short- and long term outcome after primary PCI and delivered medical care for ST-segment elevation myocardial infarction EuroIntervention 5 2010 780 787
12. Q. Zhang, J.P. Qiu, and R.Y. Zhang Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing sirolimus-eluting stent based primary coronary intervention: a report from Shanghai Acute Coronary Event (SACE) Registry Chin Med J 123 2010 782 788
13. A. Bufe, J. Wolfertz, and W. Dinh Gender-based differences in long-term outcome after ST elevation myocardial infarction in patients treated with percutaneous coronary intervention J Womens Health 19 2010 471 475
14. S.S. Brar, M.B. Leon, and G.W. Stone Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 2009 1677 1689
15. G. De Luca, G.W. Stone, and H. Suryapranata Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials Int J Cardiol 133 2009 213 222
16. P.G. Steg, K.A. Fox, and K.A. Eagle Global Registry of Acute Coronary Events (GRACE) Investigators. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J 30 2009 321 329
17. M. Valgimigli, G. Campo, and G. Percoco Multicentre Evaluation of Single High-Dose Bolus Tirofiban vs Abciximab With Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Investigators. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799 (Pubitemid 351549970)
18. D.E. Cutlip, S. Windecker, and R. Mehran Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
19. E. Solinas, E. Nikolsky, and A.J. Lansky Gender-specific outcomes after sirolimus-eluting stent implantation J Am Coll Cardiol 50 2007 2111 2116 (Pubitemid 350117340)
20. Y. Onuma, N. Kukreja, and J. Daemen Interventional Cardiologists of Thorax Center. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries JACC Cardiovasc Interv 2 2009 603 610
21. J.D. Abbott, H.A. Vlachos, and F. Selzer National Heart, Lung, and Blood Institute Dynamic Registry. Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 99 2007 626 631
22. J. Mehilli, A. Kastrati, and H. Bollwein Gender and restenosis after coronary artery stenting Eur Heart J 24 2003 1523 1530 (Pubitemid 37010583)
23. D.R. Holmes Jr, D.J. Kereiakes, and S. Garg Stent thrombosis J Am Coll Cardiol 56 2010 1357 1365
24. K.W. Park, S.J. Hwang, and D.A. Kwon Korea Stent Thrombosis Investigators. Characteristics and predictors of drug-eluting stent thrombosis. Results from the multicenter 'Korea Stent Thrombosis (KoST)' Registry Circ J 75 2011 1626 1632
25. T. Kimura, T. Morimoto, and K. Kozuma Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) Circulation 122 2010 52 61